Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Neurosurgery|January 1, 1994
A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysmsD Samson, H H Batjer, G Bowman, et al.
Cell Death & Disease|March 3, 2011
Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteinsB Schneider, S Münkel, A Krippner-Heidenreich, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
Cimicifuga racemosa Extract Ze 450 Re-Balances Energy Metabolism and Promotes LongevityMalena Rabenau, Benjamin Dillberger, Madeline Günther, et al.
Biochimica Et Biophysica Acta|March 2, 2010
Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptorsMargarita Gerken, Anja Krippner-Heidenreich, Steffen Steinert, et al.
Molecular Pharmaceutics|April 9, 2008
The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimersLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
Arthritis and Rheumatism|October 10, 2012
Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblastsThomas Hügle, Steven O'Reilly, Rachel Simpson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 19, 2021
Pharmacokinetic study of the novel phosphocholine derivative 3-dibutylaminopropylphosphonic acid by LC-MS couplingMichel G Kather, Johannes Zeller, Dietmar Plattner, et al.
Biopolymers|October 5, 1997
DNA-binding studies of XSPTSPSZ, derivatives of the intercalating heptad repeat of RNA polymerase IIM M Harding, G Y Krippner, C J Shelton, et al.
Bioconjugate Chemistry|November 17, 2005
Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responsesSusanne Bryde, Ingo Grunwald, Angela Hammer, et al.
Plos One|July 23, 2013
The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout miceSih Min Tan, Arpeeta Sharma, Derek Y C Yuen, et al.
Pageof 12